Thomas Zeyen

Bonn, NW 53127, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications

The BLTT (Bonn Leistungs Tracking Test) in Patients with Temporal Lobe Gliomas-Feasibility of a Novel Neurocognitive Test Battery.

The BLTT (Bonn Leistungs Tracking Test) in Patients with Temporal Lobe Gliomas-Feasibility of a Novel Neurocognitive Test Battery.

Journal: NeuroSci
Published: June 26, 2026

APTw CEST MRI in therapy-naive IDH-wildtype glioblastoma: insights into tumor heterogeneity and molecular subtypes.

APTw CEST MRI in therapy-naive IDH-wildtype glioblastoma: insights into tumor heterogeneity and molecular subtypes.

Journal: Journal of neuro-oncology
Published: March 27, 2026

Lomustine with or without procarbazine in recurrent glioblastoma-A propensity score matching analysis.

Lomustine with or without procarbazine in recurrent glioblastoma-A propensity score matching analysis.

Journal: Neuro-oncology advances
Published: February 20, 2026

Assessment of multimodal CEST, perfusion and diffusion MRI for predicting clinical outcome of patients with diffuse glioma following surgery at baseline before radiotherapy.

Assessment of multimodal CEST, perfusion and diffusion MRI for predicting clinical outcome of patients with diffuse glioma following surgery at baseline before radiotherapy.

Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: December 26, 2025

Chemical exchange saturation transfer (CEST) imaging reveals tumor-specific molecular changes in adult gliomas after radiotherapy.

Chemical exchange saturation transfer (CEST) imaging reveals tumor-specific molecular changes in adult gliomas after radiotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 26, 2025

Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study.

Immunodeficiency-associated primary CNS lymphomas: An International Primary CNS Lymphoma Collaborative Group (IPCG) Study.

Journal: Blood
Published: September 30, 2025

Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Immunodeficiency-associated primary CNS lymphomas: an International Primary CNS Lymphoma Collaborative Group study.

Journal: Blood
Published: September 30, 2025

Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study.

Reirradiation of recurrent glioblastoma: Results from a single-center retrospective cohort study.

Journal: Clinical and translational radiation oncology
Published: July 20, 2025

Intraoperative radiotherapy for resectable brain metastases: a systematic review and meta-analysis.

Intraoperative radiotherapy for resectable brain metastases: a systematic review and meta-analysis.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: July 07, 2025

Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safety.

Second-line temozolomide in first recurrent MGMT-methylated glioblastoma after lomustine/temozolomide: Efficacy and safety.

Journal: Neuro-oncology advances
Published: June 27, 2025

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.

L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trial.

Journal: Nature communications
Published: May 01, 2025

Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma.

Amide proton transfer-weighted (APTw) CEST MRI in clinical routine for single time point diagnosis of pseudoprogression in IDH-wildtype glioblastoma.

Journal: Neuro-oncology
Published: March 26, 2025
Showing 1-12 of 41

Last Updated: 09/26/2026